Charlotte's Web Q3 revenue $11.5M (-8.6% YoY); net loss $5.9M; targets $9M cost savings in 2026

Charlotte's Web Holdings, Inc.

2025-Q3 EPS reported -$0.12 revenue$36,571,000

Revenue $11.5M vs $12.6M in Q3 2024; gross margin 38.9% (down from 53%) due to $0.5M B2B chargeback reserve and in-house manufacturing ramp.
SG&A fell 23.3% to $9.7M; adjusted EBITDA improved to $(2.1)M from $(3.9)M; cash $9.8M, working capital $25.6M.
B2B channel restructured: direct sales force cut, $0.5M reserve recorded; management expects margin rebound to ~50% in Q4 2025.
New Brightside hemp-derived delta-9 gummies launched; CBN Stay Sleep Gummies became second-best-selling gummy; functional mushroom portfolio expanding.
U.S. Senate CR included hemp THC limit language effective 365 days post-enactment; DeFloria IND Phase 2 trial for ASD cleared; board adds British American Tobacco nominee.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.